From Bench to Bedside: The Story of CoreTag’s Targeted Radiotherapy
Time: 1:30 pm
day: Conference Day 2
Details:
- Exploring the discovery and development of CoreTags lead targeted radiopharmaceutical asset, and challenges in early development
- Addressing preclinical challenges and showcasing strategies to overcome translational bottlenecks
- Looking to the future: What is next for Core Tag?
